Capitalizing on competition: an evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment
From MaRDI portal
Publication:1714310
DOI10.1016/j.jtbi.2018.07.028zbMath1406.92329OpenAlexW2884246550WikidataQ57467565 ScholiaQ57467565MaRDI QIDQ1714310
Paul K. Newton, Yongqian Ma, Jeffrey West
Publication date: 31 January 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519622
adaptive controlreplicator dynamicsevolutionary game theoryevolutionary dynamicsprisoner's dilemmacompetitive releaseadaptive therapychemotherapeutic resistancemetastatic castration-resistant prostate cancer
Related Items
The contribution of evolutionary game theory to understanding and treating cancer, Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer, COVID-19 vaccine incentive scheduling using an optimally controlled reinforcement learning model, Cooperative success in epithelial public goods games, Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives
Uses Software
Cites Work
- Unnamed Item
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- An Evolutionary Model of Tumor Cell Kinetics and the Emergence of Molecular Heterogeneity Driving Gompertzian Growth